On-demand webinar

The importance of diverse patient group representation in clinical breast cancer trials and the role of patient education

AUG 29, 2022 · 18 min watch
Eileen Connolly, MD
Author

Eileen Connolly, MD

Assistant Professor of Radiation Oncology at New York Presbyterian/Columbia University Medical Center in New York, NY, USA

Summary

A diverse patient group representation in clinical breast cancer trials and transparent patient education as key success-drivers for modern breast cancer management

In this interview, Eileen Connolly, MD discusses the importance of diverse patient group representation in clinical breast cancer trials and the role of patient education from her perspective as radiation oncologist.

First, she addresses disease-related characteristics of breast cancer patients that may affect treatment decisions, how environmental factors influence breast cancer treatment, and typical patient needs and challenges during the course of breast cancer treatment. Following, she then points out the importance of patient diversity in clinical trials, current barriers in breast cancer research, and how existing disparities can be overcome to achieve more equal patient representation. She also highlights what physicians can already do today to improve breast cancer care and why a transparent and individual and why a transparent and individual patient education is incremental for a successful and modern breast cancer program.

  • The doctor shown in this video has a contractual or other financial relationship with Carl Zeiss Meditec AG and has received financial support.

Share this article